PKIS v2.0 A clinical tool for identifying important pharmacokinetic drug-drug interactions
| 1. Accepted major perpetrators | 2. Rejected perpetrators | 3. Unclassifiable | 4. Full table |

melperone

  • melperone is not available in Australia/New Zealand, despite evidence suggesting that it may perturb the activities of CYP2D6.
  • CYP2D6
    Not available in Australia or New Zealandclemastine
    deramciclan
    halofantrine
    hydroxyzine
    levomepromazine
    melperone
    mepyramine
    mibefradil
    midodrine
    perphenazine
    propafenone
    quinidine
    ranolazine
    rofecoxib
    stiripentol
    thioridazine
    tripelennamine

    Footnotes and References

    Disclaimer
    WARNING: While all efforts were put in to maintain the accuracy and currency of the information, it is possible that the knowledge and electronic tools may contain errors and inadequacy. Both Flinder's University and University of New South Wales are not liable to any damages or losses resulted from such circumstances. Clinical discretions are strongly advised at all times.